GU Cancers Symposium 2014 - An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post-chemotherapy - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by Tracy Li, Melissa Thompson, Mary Beth Todd, Margaret K. Yu, Thian San Kheoh, Jianming He, and Ryan Saadi at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 -2014 AA Cost-effectiveness-poster Li thumb

Janssen Global Services, Raritan, NJ; Cornerstone Research Group, Inc., Burlington, ON, Canada; Janssen Research & Development, LLC, Los Angeles, CA; Jassen Global Services, Raritan, NJ

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe